EvexiPEL
EvexiPEL is a Texas-based hormone replacement therapy brand under EVEXIAS Health Solutions that delivers patented bioidentical hormone pellet therapy through a national network of certified practitioners and two flagship clinics, serving adults with hormone imbalance, menopause, and andropause symptoms.
- Company typePrivate
- Founded2018
- HeadquartersSouthlake, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What EvexiPEL does
EvexiPEL is a hormone replacement therapy (HRT) brand and clinical method operated by EVEXIAS Health Solutions, a Texas-based private healthcare company founded by Dr. Terri DeNeui. The company delivers bioidentical estradiol and testosterone pellet therapy through a network of EvexiPEL Certified Providers across the United States, supplemented by two company-operated EVEXIAS Medical Centers in Southlake, TX and Rockwall, TX. Its core technology combines a patented hormone pellet formulation — produced in an FDA 503B registered outsourcing facility and including trace amounts of an anti-inflammatory — with a proprietary insertion technique also developed by Dr. DeNeui, designed to deliver steady hormone dosing over 3–5 months (women) or 4–6 months (men) via a 15–30 minute in-office procedure.
The business operates a two-sided go-to-market: a direct-to-consumer motion using content marketing, social media, and a provider finder tool to direct prospective patients to certified practitioners, paired with an enterprise field sales motion that recruits and certifies healthcare providers into the network. Revenue is generated indirectly through pellet shipments and procedure fees at certified clinics, plus direct service revenue at the Texas flagship centers, with most lab testing and consultations covered by insurance and pellet therapy coverage varying by insurer. Personalized treatment plans may include progesterone, thyroid hormones, nutraceuticals, and lifestyle recommendations.
No external institutional funding, public listing, or headcount figures are disclosed. The company holds no identified patents or trademarks in the source data beyond the referenced patented pellet formulation, and there are no recorded M&A, regulatory actions, or leadership changes on file. Strategic emphasis is on expanding the certified provider base and DTC patient acquisition, as evidenced by a Q4 2023 multi-city billboard campaign in Dallas, Fort Lauderdale, and Phoenix.
EvexiPEL firmographics
Firmographics- Name
- EvexiPEL
- Legal name
- EVEXIAS Health Solutions
- Website
- https://pellet.life
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- EvexiPEL is a Texas-based hormone replacement therapy brand under EVEXIAS Health Solutions that delivers patented bioidentical hormone pellet therapy through a national network of certified practitioners and two flagship clinics, serving adults with hormone imbalance, menopause, and andropause symptoms.
- Ownership category
- akta.pro rank
Where EvexiPEL is headquartered
LocationHeadquarters
- HQ city
- Southlake
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
EvexiPEL business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Supply Chain, Technology or R&D
Revenue model
- Hormone Therapy Services: EvexiPEL generates revenue through hormone pellet therapy services delivered by certified practitioners. Services include consultation, hormone testing, pellet insertion procedures, and ongoing monitoring throughout treatment cycles of 3-5 months.
- Laboratory Testing: Hormone lab testing services for evaluating hormone levels and determining candidacy for therapy. Most labs and consultations are covered by insurance.
- Nutraceuticals and Lifestyle Products: Treatment plans may include nutraceuticals and lifestyle recommendations as part of comprehensive hormone optimization programs.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
EvexiPEL product offering
Product offeringCore offering
EvexiPEL provides a proprietary hormone replacement therapy (HRT) method centered on patented bioidentical estradiol and testosterone pellets formulated with trace amounts of an anti-inflammatory and produced in an FDA 503B registered outsourcing facility. The pellets are inserted via a proprietary technique developed by Dr. Terri DeNeui, delivering steady-state hormone levels for 3-5 months in women and 4-6 months in men. Treatment is delivered through a national network of EvexiPEL Certified Providers and two company-operated EVEXIAS Medical Centers in Texas, with supporting offerings including personalized treatment plans, hormone lab testing, and a practitioner certification program.
Product overview
EvexiPEL is a hormone therapy company offering a unified method combining patented hormone pellets with a proprietary insertion technique. The core product is the EvexiPEL Method for estradiol and testosterone pellet therapy, delivered through an in-office insertion procedure (15-30 minutes) that provides 3-5 months of steady hormone dosing. Treatment is administered exclusively through EvexiPEL Certified Providers who create personalized treatment plans that may also include progesterone, thyroid hormones, and nutraceuticals. The company operates under EVEXIAS Health Solutions and maintains an FDA 503B outsourcing facility for pellet production.
Differentiator
Problem solved
Functional benefit
Brands
- EvexiPEL Method: Proprietary hormone replacement therapy (HRT) method featuring patented hormone pellets and a proprietary insertion technique, offered exclusively through EVEXIAS Health Solutions.
Products and services
- EvexiPEL Method A proprietary hormone pellet therapy method for estradiol and testosterone replacement, combining patented hormone pellets developed in an FDA 503B outsourcing facility with a proprietary insertion technique designed to reduce bruising, minimize scar tissue, and provide steady hormone dosing over 3-5 month treatment cycles. Delivered exclusively through EvexiPEL Certified Providers to adult men and women with hormone imbalance.
- Hormone Pellet Insertion Procedure A 15-30 minute in-office procedure involving a small incision to insert hormone pellets beneath the skin, designed to be minimally invasive with reduced pain and bruising compared to traditional pellet therapy. Performed by EvexiPEL Certified Providers for individual patients.
- Personalized Hormone Optimization Treatment Plans Customized hormone optimization programs that may include estradiol and testosterone pellet therapy, progesterone, thyroid hormones, nutraceuticals, and lifestyle recommendations tailored to individual patient lab results, medical history, and symptoms. Offered to patients by EvexiPEL Certified Providers.
- EvexiPEL Certified Provider Network A nationwide network of healthcare practitioners trained and certified in the EvexiPEL Method, offering hormone therapy services through private medical practices with advanced medical education and training from industry-leading practitioners and researchers. Accessed by individual patients via the provider finder tool.
Quantifiable outcome
- Steady hormone delivery for 3-5 months in women, 4-6 months in men
- +3 more outcomes
Companies that use EvexiPEL
Customer profileNamed customers8 records
Segments2 records
Ideal customer profiles2 records
EvexiPEL technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
EvexiPEL partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- EvexiPEL Certified PractitionerscoreNetwork of healthcare practitioners certified in the EvexiPEL Method who deliver hormone pellet therapy services. Certified providers receive advanced medical education, training, and access to proprietary therapies and technologies. Practitioners can enhance patient care and grow their practices through the program.
- FDA 503B Registered Outsourcing FacilitycoreManufacturing partner producing EvexiPEL patented hormone pellets in an FDA 503B registered outsourcing facility. The facility ensures purity, potency, and precise dosing of pellets with trace amounts of anti-inflammatory formulation.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
EvexiPEL competitors and assessment
Company assessmentBroad incumbents
- EVEXIAS Health Solutions: EVEXIAS Health Solutions is EvexiPEL's parent company and offers a broader portfolio of wellness, nutraceutical, and training products beyond the EvexiPEL Method. It is the same operating entity viewed at the parent level rather than as the flagship pellet brand.
- Allergan / AbbVie (e.g., AndroGel, estradiol franchises): Large pharmaceutical companies market FDA-approved HRT products (patches, gels, injectables) that compete with EvexiPEL's pellets for the same hormone-replacement prescriptions. They represent the established, mass-market alternative to compounded pellet therapy.
Direct peers
- BioTE Medical: BioTE is the largest U.S. hormone pellet therapy network, distributing bioidentical hormone pellets through a national certified-provider program. Its business model — proprietary pellet, certification curriculum, recurring insertion cycles — is the closest direct analogue to EvexiPEL.
- Pellecome: Pellecome provides a hormone pellet product and trains practitioners in pellet insertion, operating a certification-based distribution model that parallels EvexiPEL's certified-provider network and recurring pellet supply economics.
- Defy Medical: Defy Medical is a clinic and telehealth provider of hormone replacement therapy, including pellet-based protocols, serving men and women with age-related hormone decline. It overlaps with EvexiPEL's patient base and treatment offerings.
- Ageless Men's Health: Ageless Men's Health operates a national chain of clinics focused on testosterone replacement and men's hormone optimization. It is a direct competitor for EvexiPEL's male patient cohort and uses a similar clinic-network growth model.
- SottoPelle: SottoPelle markets its own proprietary subcutaneous hormone pellet therapy and trains physicians in its proprietary insertion technique, mirroring EvexiPEL's combination of patented pellet plus proprietary insertion method delivered through certified providers.
- BodyLogicMD: BodyLogicMD is a national network of physicians specializing in bioidentical hormone replacement therapy and preventive wellness for men and women. It competes directly with EvexiPEL for the same mid-life hormone optimization patient segment and practitioner relationships.
Emerging players
- Marek Health: Marek Health is a men's hormone optimization and TRT provider operating via telehealth and partner clinics. It is an emerging competitor pursuing the same male hormone replacement demand with a more digital-first delivery model.
- Winona: Winona is a telehealth platform providing bioidentical hormone replacement therapy, primarily to women in perimenopause and menopause. It competes for the same women's hormone optimization demand as EvexiPEL but via a remote prescribing model rather than in-office pellets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
EvexiPEL social profiles
Digital presenceEvexiPEL compliance and trust
Trust signalCompliance1 record
EvexiPEL financial estimates
Financial estimateRevenue estimate
Valuation estimate
EvexiPEL leadership team
Management profileNumber of profiles
Profiles1 record
EvexiPEL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EvexiPEL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EvexiPEL
What does EvexiPEL do?
EvexiPEL provides a proprietary hormone replacement therapy (HRT) method centered on patented bioidentical estradiol and testosterone pellets formulated with trace amounts of an anti-inflammatory and produced in an FDA 503B registered outsourcing facility. The pellets are inserted via a proprietary technique developed by Dr. Terri DeNeui, delivering steady-state hormone levels for 3-5 months in women and 4-6 months in men. Treatment is delivered through a national network of EvexiPEL Certified Providers and two company-operated EVEXIAS Medical Centers in Texas, with supporting offerings including personalized treatment plans, hormone lab testing, and a practitioner certification program.
Is EvexiPEL a public or private company?
EvexiPEL is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was EvexiPEL founded?
EvexiPEL was founded in 2018. It employs 11 to 50 people.
Where is EvexiPEL based?
EvexiPEL is headquartered in Southlake, United States, in the North America region.
How does EvexiPEL make money?
Three revenue lines are on record. Hormone Therapy Services are the primary driver. The others are laboratory Testing and nutraceuticals and Lifestyle Products.
Who are EvexiPEL's main competitors?
Broad incumbents on record are EVEXIAS Health Solutions and Allergan / AbbVie (e.g., AndroGel, estradiol franchises). Direct peers are BioTE Medical, Pellecome, Defy Medical, Ageless Men's Health, SottoPelle and BodyLogicMD. Emerging players are Marek Health and Winona.
Does EvexiPEL have an API?
No public API is recorded for EvexiPEL.